Stay updated on SPX-101 Inhalation Solution in CF Clinical Trial
Sign up to get notified when there's something new on the SPX-101 Inhalation Solution in CF Clinical Trial page.

Latest updates to the SPX-101 Inhalation Solution in CF Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check17 days agoChange DetectedThe page has undergone significant content changes regarding the clinical trial for SPX-101 Inhalation Solution for cystic fibrosis, with the removal of detailed study descriptions and criteria, while retaining some key terms and the revision number.SummaryDifference7%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check75 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check89 days agoChange DetectedThe webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check96 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to SPX-101 Inhalation Solution in CF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPX-101 Inhalation Solution in CF Clinical Trial page.